|
| 36528475 | Comparing dosimetry of locally advanced cervical cancer patients treated with 3 versus 4 fractions of MRI-guided brachytherapy. | Brachytherapy | 2023 |
| 37380217 | A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers. | Int J Gynecol Cancer | 2023 |
| 37397861 | Multi-institutional Prognostic Modeling in Head and Neck Cancer: Evaluating Impact and Generalizability of Deep Learning and Radiomics. | Cancer Res Commun | 2023 |
| 37357051 | A two-center experience: The impact of COVID-19 on two brachytherapy programs in Ontario - virtual care, service suspension and radiation therapy workflow. | J Med Imaging Radiat Sci | 2023 |
| 34894495 | Impact of PET scanner non-linearity on the estimation of hypoxic fraction in cervical cancer patients. | Phys Med | 2022 |
| 35621686 | Striving to Fill in Gaps between Clinical Practice and Standards: The Evolution of a Pan-Canadian Approach to Patient-Reported Outcomes Use. | Curr Oncol | 2022 |
| 36541560 | Incorporating cross-voxel exchange for the analysis of dynamic contrast-enhanced imaging data: pre-clinical results. | Phys Med Biol | 2022 |
| 36037303 | A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer. | Clin Cancer Res | 2022 |
| 35951324 | Geographic Accessibility and Availability of Radiotherapy in Ghana. | JAMA Netw Open | 2022 |
| 34942281 | Provincial variations in radiotherapy utilization as a measure of access: A pan-Canadian study. | Radiother Oncol | 2022 |
| 34650009 | Incorporating cross-voxel exchange into the analysis of dynamic contrast-enhanced imaging data: theory, simulations and experimental results. | Phys Med Biol | 2021 |
| 33771702 | The Oral CXCR4 Inhibitor X4-136 Improves Tumor Control and Reduces Toxicity in Cervical Cancer Treated With Radiation Therapy and Concurrent Chemotherapy. | Int J Radiat Oncol Biol Phys | 2021 |
| 31274700 | HPV-independent Vulvar Squamous Cell Carcinoma is Associated With Significantly Worse Prognosis Compared With HPV-associated Tumors. | Int J Gynecol Pathol | 2020 |
| 32798179 | More than learning technical skills: The importance of mentorship and coaching during a brachytherapy fellowship. | Brachytherapy | 2020 |
| 32673779 | Management of gynecologic cancer: Choosing radiotherapy wisely by 3 Southern Ontario academic centers during the COVID-19 pandemic. | Radiother Oncol | 2020 |
| 32169410 | A Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy Versus Two-Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical Cancer. | Int J Radiat Oncol Biol Phys | 2020 |
| 32135119 | Definitive radiotherapy with image-guided adaptive brachytherapy for primary vaginal cancer. | Lancet Oncol | 2020 |
| 32368623 | Long-term patient-reported distress in locally advanced cervical cancer patients treated with definitive chemoradiation. | Clin Transl Radiat Oncol | 2020 |
| 30509730 | Patient-reported sexual adjustment after definitive chemoradiation and MR-guided brachytherapy for cervical cancer. | Brachytherapy | 2019 |
| 31650046 | Intratumoral heterogeneity and hypoxia gene expression signatures: Is a single biopsy adequate? | Clin Transl Radiat Oncol | 2019 |
| 31503063 | Clinical Outcomes of Surgically Unresectable Endometrial Cancers. | Am J Clin Oncol | 2019 |
| 31239542 | Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy. | Br J Cancer | 2019 |
| 31399696 | Correction: Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy. | Br J Cancer | 2019 |
| 31015155 | Repeatability and reproducibility of MRI-based radiomic features in cervical cancer. | Radiother Oncol | 2019 |
| 31151906 | Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact. | Lancet Oncol | 2019 |
| 31039422 | National Trends and Dynamic Responses in the Canadian Radiation Oncology Workforce From 1990 to 2018. | Int J Radiat Oncol Biol Phys | 2019 |
| 30416044 | Vulnerabilities of radiomic signature development: The need for safeguards. | Radiother Oncol | 2019 |
| 28757402 | Brachytherapy patient safety events in an academic radiation medicine program. | Brachytherapy | 2018 |
| 35135145 | Circulating Human Papillomavirus DNA as a Biomarker of Response in Patients With Locally Advanced Cervical Cancer Treated With Definitive Chemoradiation. | JCO Precis Oncol | 2018 |
| 30144083 | Improving patient outcomes and radiotherapy systems: A pan-Canadian approach to patient-reported outcome use. | Med Phys | 2018 |
| 30004666 | Radiation and Heat Improve the Delivery and Efficacy of Nanotherapeutics by Modulating Intratumoral Fluid Dynamics. | ACS Nano | 2018 |
| 29449057 | Prognostic Significance of Human Papilloma Virus and p16 Expression in Patients with Vulvar Squamous Cell Carcinoma who Received Radiotherapy. | Clin Oncol (R Coll Radiol) | 2018 |
| 29726389 | Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology. | Lancet Oncol | 2018 |
| 29417588 | Targeting the CXCL12/CXCR4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer. | Int J Cancer | 2018 |
| 29406125 | Technique adaptation, strategic replanning, and team learning during implementation of MR-guided brachytherapy for cervical cancer. | Brachytherapy | 2018 |
| 29681500 | Moving toward uniform and evidence-based practice of radiotherapy for management of cervical cancer in Ontario, Canada. | Brachytherapy | 2018 |
| 29680257 | Measurement of Tumor Hypoxia in Patients With Locally Advanced Cervical Cancer Using Positron Emission Tomography with <sup>18</sup>F-Fluoroazomyin Arabinoside. | Int J Radiat Oncol Biol Phys | 2018 |
| 29426638 | Comparison of dosimetric parameters derived from whole organ and wall contours for bladder and rectum in cervical cancer patients treated with intracavitary and interstitial brachytherapy. | Radiother Oncol | 2018 |
| 29264974 | Quality in cancer care: Lessons from the Canadian partnership for quality radiotherapy. | Healthc Manage Forum | 2018 |
| 27262923 | Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery. | Adv Drug Deliv Rev | 2017 |
| 28109627 | A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers. | Gynecol Oncol | 2017 |
| 28410011 | Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic. | J Clin Oncol | 2017 |
| 28333001 | The Practice of Radiation Oncology in Canada. | Int J Radiat Oncol Biol Phys | 2017 |
| 28332000 | Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival. | J Neurooncol | 2017 |
| 28495284 | Genomic biomarkers for precision radiation medicine. | Lancet Oncol | 2017 |
| 29594218 | The predictive value of nadir neutrophil count during treatment of cervical cancer: Interactions with tumor hypoxia and interstitial fluid pressure (IFP). | Clin Transl Radiat Oncol | 2017 |
| 29273939 | Impact of tissue transport on PET hypoxia quantification in pancreatic tumours. | EJNMMI Res | 2017 |
| 29270061 | Strategic planning in an academic radiation medicine program. | Curr Oncol | 2017 |
| 28668472 | Phase I dose escalation study of concurrent palliative radiation therapy with sorafenib in three anatomical cohorts (Thorax, Abdomen, Pelvis): The TAP study. | Radiother Oncol | 2017 |
| 28619042 | Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors. | BMC Cancer | 2017 |